# Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome?

> **NCT01714648** · PHASE4 · TERMINATED · sponsor: **Elisha Hospital** · enrollment: 6 (actual)

## Conditions studied

- Ovarian Hyperstimulation Syndrome

## Interventions

- **DRUG:** Triptorelin 0.2 mg

## Key facts

- **NCT ID:** NCT01714648
- **Lead sponsor:** Elisha Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Terminated: recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated
- **Last updated:** 2015-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01714648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01714648, "Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome?". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01714648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*